Rudd P, Tul V, Brown K, Davidson S M, Bostwick G J
Arch Intern Med. 1979 May;139(5):545-9. doi: 10.1001/archinte.139.5.545.
We analyzed a random sample of general medicine clinic patients to determine the natural history of newly treated hypertensive (NH) patients: discontinuation patterns, critical intervention periods, and hypertension's (HBP) utility as an indicator condition. The NH patients exhibited a 48% dropout rate in the first year and better continuation adherence than new nonhypertensive (NNH) patients. Patients with HBP and other chronic diseases had better continuation adherence than those with HBP alone, although no predictive patterns emerged. New patients displayed rapid early discontinuation, with further linear decline by four months for NNH and by eight months for NH patients. All patients showed similar subsequent falloff: linear annual decline at 13% to 36%. We conclude that discontinuation rates are unacceptably high, that interventions must be continued throughout treatment, and that HBP has limited utility as an indicator chronic disease.
我们分析了普通内科门诊患者的随机样本,以确定新治疗的高血压患者的自然病程:停药模式、关键干预期以及高血压作为指示疾病的效用。高血压患者在第一年的脱落率为48%,且其持续依从性优于新的非高血压患者。患有高血压和其他慢性病的患者比仅患有高血压的患者具有更好的持续依从性,尽管未出现预测模式。新患者早期停药迅速,非高血压患者在四个月时、高血压患者在八个月时进一步呈线性下降。所有患者随后的下降情况相似:每年呈13%至36%的线性下降。我们得出结论,停药率高得令人无法接受,干预措施必须贯穿整个治疗过程,并且高血压作为指示慢性病的效用有限。